Outcomes Examined for Cannabis Users After Lower-Extremity Bypass
FRIDAY, Dec. 2, 2022 -- For patients undergoing lower-extremity bypass, cannabis use is associated with reduced graft patency, increased amputation, and increased opioid use, according to a study published online Sept. 22 in the Annals of Vascular... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 2, 2022 Category: Pharmaceuticals Source Type: news

Preexisting Type 2 Diabetes Tied to Later Stage of Cancer Diagnosis
FRIDAY, Dec. 2, 2022 -- Individuals with type 2 diabetes face an increased risk for advanced tumor stage at cancer diagnosis, particularly for nonscreenable cancers, according to a study presented at the annual European Breast Cancer Conference,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 2, 2022 Category: Pharmaceuticals Source Type: news

988 Mental Health Hotline Back in Business After Daylong Outage
FRIDAY, Dec. 2, 2022 -- The national hotline that people can call in a mental health emergency went down for a day before it was restored late Thursday. Those in crisis could still reach counselors by texting 988 or visiting 988lifeline.org during... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 2, 2022 Category: Pharmaceuticals Source Type: news

Explaining China's Zero Covid Policy And Why It Has Sparked Protests Nationwide
Demonstrators have taken to the streets across China in opposition of the country ’s strict zero-Covid policy. This marks one of the greatest public shows of defiance against the ruling Communist Party in decades. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 2, 2022 Category: Pharmaceuticals Tags: Leadership /leadership Healthcare /healthcare Source Type: news

A glimmer of hope in treating Alzheimer’s disease
Dementia drug development, diagnostics and delivery still require much more investment (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - December 2, 2022 Category: Pharmaceuticals Source Type: news

Covid Still Killed Over 9,000 Americans In November, As Attention To It (And Boosters) Declines
The number of people dying with Covid in November was similar to death rates from excessive alcohol consumption and around two to four times deaths from flu, firearms, motor traffic accidents and opioid overdoses. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 2, 2022 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus Evergreen Source Type: news

Economic impact of SA health care and bioscience industry tops $44B
The sector has grown by nearly $2 billion over the last two years. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 2, 2022 Category: Pharmaceuticals Authors: W. Scott Bailey Source Type: news

Lab Notes: Context identifies lead cancer drug candidate; Aclaris inks licensing deal worth up to $96M
This week's Philadelphia-area life sciences industry update includes a women's oncology company identifying a lead product candidate, a biopharmaceutical company's multimillion-dollar licensing deal, a biotech firm initiating human clinical trials, and more. Here's the roundup: The Philadelphia-based women's oncology company selected CTIM-76 as its lead clinical development candidate targeting Claudin 6 (CLDN6) positive cancers. CLDN6-enriched cancers include ovarian, endometrial, testicular, … (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 2, 2022 Category: Pharmaceuticals Authors: John George Source Type: news

More Biosimilars Marketed in Germany, Switzerland Than U.S.
FRIDAY, Dec. 2, 2022 -- More biosimilars have been marketed in Germany and Switzerland than in the United States, but uptake has increased over time in all countries, according to a study published online Dec. 2 in JAMA Network Open. David L. Carl,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 2, 2022 Category: Pharmaceuticals Source Type: news

Study Looks at Extent of Residual Lung Abnormalities After COVID-19 Hospitalization
FRIDAY, Dec. 2, 2022 -- Residual lung abnormalities are estimated in up to about 11.7 percent of patients discharged following COVID-19-related hospitalization, according to a study published online Dec. 2 in the American Journal of Respiratory and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 2, 2022 Category: Pharmaceuticals Source Type: news

Health care giant Encompass growing to meet needs
Encompass is growing in leaps and bounds. The health care giant had 1,725 Alabama employees and $105.4 million in Alabama salaries, according to 2021 data. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 2, 2022 Category: Pharmaceuticals Authors: Laurel Thrailkill Source Type: news

Prevalence of Methamphetamine-Related Heart Failure Increasing
FRIDAY, Dec. 2, 2022 -- The prevalence of methamphetamine-associated heart failure (MethHF) is increasing and is associated with significant morbidity, according to a review published online Dec. 1 in Heart. Veena Manja, Ph.D., from the VA Center... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 2, 2022 Category: Pharmaceuticals Source Type: news

Despite Eye-Popping $3.5 Million Price Tag For Gene Therapy Hemgenix, Budget Impact For Most Payers Will Be Relatively Small
The first gene therapy for hemophilia B, Hemgenix, will have a list price of $3.5 million per use. This sets a new record for the most expensive single-use gene therapy in the U.S. In spite of the very high price tag, the budgetary impact of the product for most payers will be comparatively small. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 2, 2022 Category: Pharmaceuticals Authors: Joshua Cohen, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news

Supraphysiological Oxygen During Surgery Linked to Organ Damage
FRIDAY, Dec. 2, 2022 -- Supraphysiological oxygen administration during surgery is associated with increased odds of kidney, myocardial, and lung injury, according to a study published online Nov. 30 in The BMJ. David R. McIlroy, M.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 2, 2022 Category: Pharmaceuticals Source Type: news

RSNA: New AI Algorithm Predicts 10-Year Cardiovascular Risk From Chest X-Ray
FRIDAY, Dec. 2, 2022 -- Deep learning can estimate cardiovascular risk from a routine chest X-ray image similar to the current clinical standard, according to a study presented at the annual meeting of the Radiological Society of North America, held... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 2, 2022 Category: Pharmaceuticals Source Type: news